Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 7,906 | 0 | 4,320 | 4,553 |
| Operating Income | -7,906 | N/A | -4,320 | -4,553 |
| Other Income | 168 | 0 | 285 | 380 |
| Pre-tax Income | -7,738 | 0 | -4,035 | -4,173 |
| Net Income Continuous | -7,738 | N/A | -4,035 | -4,173 |
| Net Income | $-7,738 | $N/A | $-4,035 | $-4,173 |
| EPS Basic Total Ops | -6.42 | N/A | -3.38 | -3.57 |
| EPS Basic Continuous Ops | -6.42 | N/A | -3.38 | -3.57 |
| EPS Diluted Total Ops | -6.42 | N/A | -3.38 | -3.57 |
| EPS Diluted Continuous Ops | -6.42 | N/A | -3.38 | -3.57 |
| EBITDA(a) | $-7,927 | $N/A | $-4,341 | $-4,553 |